Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial (Q56928579)
Jump to navigation
Jump to search
scientific article published in The Lancet
Language | Label | Description | Also known as |
---|---|---|---|
English | Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial |
scientific article published in The Lancet |
Statements
Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (English)
R M Califf
E Cohen
J Burton
N Kleiman
D Talley
S Sapp
J Booth
C F Cabot